Home Air Quality Impact for Adults With Asthma
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT05224076
- Status
- Completed
Conditions
- Asthma
- Environmental Exposure
- Home Environment Related Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Home Air Quality — OTHERThis study will assess the feasibility and usability of ecological momentary assessment (EMA) to capture the context of real time behaviors and environmental exposures that impact indoor environments. In addition, the study will assess the feasibility and usability of providing participants with a readily available indoor home air quality monitor to continuously capture total volatile organic compounds (VOCs) and particulates (PM2.5).
Study Details
The purposes of this study are to determine the practicality of using home indoor air quality monitoring and a smartphone app to identify home air quality changes and how these changes affect adults with asthma.
Key Dates
- Start date
- Mar 30, 2022
- Status verified
- Jul 2025
- Primary completion
- Feb 28, 2024
- Completion
- Feb 28, 2024
Study Design
- Enrollment
- 64 participants (actual)
Primary Outcome Measure
Episodes Per Day [ Time Frame: Measured daily for 14 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barbara J Polivka | Kansas City | Kansas | 66160 | - |
Find similar trials in Kansas City, KS
By condition
By specialty
By research site
Related Studies
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary DiseasePHASE1 · Recruiting · Mario Castro, MD, MPH · Kansas City, Kansas
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPHASE3 · Recruiting · AstraZeneca · Anchorage, Alaska
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaPHASE2 · Recruiting · Sanofi · Saraland, Alabama
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPHASE2 · Recruiting · AstraZeneca · Bakersfield, California